You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Partner and Locator of BRCA2 (PALB2)

Showing 1 - 25 of 1,147
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022

    Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

    Active, not recruiting
    • Pancreatic Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Nov 10, 2021

    HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

    Recruiting
    • HER2-negative Breast Cancer
    • +2 more
    • Barcelona, Spain
    • +4 more
    Apr 14, 2022

    BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

    Not yet recruiting
    • BRCA Mutation
    • +3 more
    • Tamoxifen 10 Mg Tablet
    • +2 more
    • Genoa, Italy
    • +3 more
    Sep 11, 2023

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    The Pancreas Interception Center for Early Detection,

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +12 more
    • Data collection
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 11, 2023

    Metastatic Castrate Resistant Prostate Cancer, BRCA1, BRCA2, PALB2 Genetic Mutations Trial in United States (Carboplatin,

    Recruiting
    • Metastatic Castrate Resistant Prostate Cancer
    • +2 more
    • West Los Angeles, California
    • +13 more
    Nov 23, 2022

    BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

    Recruiting
    • BARD1 Gene Mutation
    • +14 more
    • Educational Intervention
    • +3 more
    • Houston, Texas
    • +1 more
    Jun 14, 2022

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    Breast Cancer Trial in China, Singapore (Prophylactic contralateral breast irradiation)

    Recruiting
    • Breast Cancer
    • Prophylactic contralateral breast irradiation
    • Jiangxi, Jiangxi, China
    • +7 more
    Jul 13, 2021

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

    Active, not recruiting
    • Deleterious BARD1 Gene Mutation
    • +13 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Chicago, Illinois
    • +8 more
    Feb 25, 2022

    Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

    Recruiting
    • Pancreas Cancer
    • +4 more
    • New Haven, Connecticut
    • +7 more
    Dec 12, 2022

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States

    Recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Biospecimen Collection
    • +4 more
    • Anchorage, Alaska
    • +357 more
    Jan 28, 2023

    Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

    Active, not recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • +4 more
    • Biopsy
    • +4 more
    • Chicago, Illinois
    • +11 more
    Jun 28, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Mar 14, 2022

    Pancreatic Cancer in Patients With Inherited Genetic Risk

    Recruiting
    • Pancreatic Cancer
    • surveillance endoscopic ultrasound or MRI of the abdomen
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jun 1, 2022

    High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

    Recruiting
    • High Grade Serous Carcinoma
    • +2 more
    • Toronto, Ontario, Canada
    • +2 more
    Nov 28, 2022

    Germline Mutations Associated With Hereditary Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • Pancreatic Adenocarcinoma
    • Invitae Multi-Cancer Panel ®
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Mar 22, 2022

    Metastatic Breast Cancer Trial in Worldwide (Placebo, Veliparib, Carboplatin)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • Placebo
    • +4 more
    • Birmingham, Alabama
    • +119 more
    Sep 27, 2021

    Tumors From Inherited Cancers Having Had Two Surgeries

    Completed
    • Breast Cancer
    • Ovarian Cancer
      • Seattle, Washington
        University of Washington
      Feb 2, 2022